These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38754632)

  • 21. Design, synthesis and discovery of 2(1H)-quinolone derivatives for the treatment of pulmonary fibrosis through inhibition of TGF-β/smad dependent and independent pathway.
    Xue L; Deng D; Zheng S; Tang M; Yang Z; Pei H; Chen Y; Yang T; Liu K; Ye H; Chen L
    Eur J Med Chem; 2020 Jul; 197():112259. PubMed ID: 32334267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergistic protection of Schizandrin B and Glycyrrhizic acid against bleomycin-induced pulmonary fibrosis by inhibiting TGF-β1/Smad2 pathways and overexpression of NOX4.
    Zhang D; Liu B; Cao B; Wei F; Yu X; Li GF; Chen H; Wei LQ; Wang PL
    Int Immunopharmacol; 2017 Jul; 48():67-75. PubMed ID: 28476015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Curdione ameliorates bleomycin-induced pulmonary fibrosis by repressing TGF-β-induced fibroblast to myofibroblast differentiation.
    Liu P; Miao K; Zhang L; Mou Y; Xu Y; Xiong W; Yu J; Wang Y
    Respir Res; 2020 Feb; 21(1):58. PubMed ID: 32075634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis.
    Araki K; Kinoshita R; Tomonobu N; Gohara Y; Tomida S; Takahashi Y; Senoo S; Taniguchi A; Itano J; Yamamoto KI; Murata H; Suzawa K; Shien K; Yamamoto H; Okazaki M; Sugimoto S; Ichimura K; Nishibori M; Miyahara N; Toyooka S; Sakaguchi M
    J Mol Med (Berl); 2021 Jan; 99(1):131-145. PubMed ID: 33169236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amifostine ameliorates bleomycin-induced murine pulmonary fibrosis via NAD
    Guo F; Xu F; Li S; Zhang Y; Lv D; Zheng L; Gan Y; Zhou M; Zhao K; Xu S; Wu B; Deng Z; Fu P
    Eur J Med Res; 2024 Jan; 29(1):68. PubMed ID: 38245795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 18β-glycyrrhetinic acid ameliorates bleomycin-induced idiopathic pulmonary fibrosis via inhibiting TGF-β1/JAK2/STAT3 signaling axis.
    Bai Y; Gao L; Han T; Liang C; Zhou J; Liu Y; Guo J; Wu J; Hu D
    J Steroid Biochem Mol Biol; 2024 Jun; 243():106560. PubMed ID: 38917955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, synthesis, and evaluation of pirfenidone-NSAIDs conjugates for the treatment of idiopathic pulmonary fibrosis.
    Lu X; Zhu C; Gao Y; Yu Z; Yan Q; Liu Y; Luo M; Shi X
    Bioorg Chem; 2024 Feb; 143():107018. PubMed ID: 38071874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The antifibrotic effect of pheretima protein is mediated by the TGF-β1/Smad2/3 pathway and attenuates inflammation in bleomycin-induced idiopathic pulmonary fibrosis.
    Li S; Yang Q; Chen F; Tian L; Huo J; Meng Y; Tang Q; Wang W
    J Ethnopharmacol; 2022 Mar; 286():114901. PubMed ID: 34890730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ajulemic acid exerts potent anti-fibrotic effect during the fibrogenic phase of bleomycin lung.
    Lucattelli M; Fineschi S; Selvi E; Garcia Gonzalez E; Bartalesi B; De Cunto G; Lorenzini S; Galeazzi M; Lungarella G
    Respir Res; 2016 May; 17(1):49. PubMed ID: 27153807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition.
    Kyung SY; Kim DY; Yoon JY; Son ES; Kim YJ; Park JW; Jeong SH
    BMC Pharmacol Toxicol; 2018 Apr; 19(1):13. PubMed ID: 29609658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Caffeic acid ethanolamide induces antifibrosis, anti-inflammatory, and antioxidant effects protects against bleomycin-induced pulmonary fibrosis.
    Huang CW; Lee SY; Du CX; Wu ST; Kuo YH; Ku HC
    Biomed Pharmacother; 2024 Apr; 173():116298. PubMed ID: 38394850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vardenafil Activity in Lung Fibrosis and In Vitro Synergy with Nintedanib.
    Bourne MH; Kottom TJ; Hebrink DM; Choudhury M; Leof EB; Limper AH
    Cells; 2021 Dec; 10(12):. PubMed ID: 34944010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Obaculactone protects against bleomycin-induced pulmonary fibrosis in mice.
    Wang X; Ouyang Z; You Q; He S; Meng Q; Hu C; Wu X; Shen Y; Sun Y; Wu X; Xu Q
    Toxicol Appl Pharmacol; 2016 Jul; 303():21-29. PubMed ID: 27180239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Zanubrutinib attenuates bleomycin-induced pulmonary fibrosis by inhibiting the TGF-β1 signaling pathway.
    Chen S; Wei Y; Li S; Miao Y; Gu J; Cui Y; Liu Z; Liang J; Wei L; Li X; Zhou H; Yang C
    Int Immunopharmacol; 2022 Dec; 113(Pt A):109316. PubMed ID: 36252483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The potential application of strategic released apigenin from polymeric carrier in pulmonary fibrosis.
    Zhang J; Chao L; Liu X; Shi Y; Zhang C; Kong L; Li R
    Exp Lung Res; 2017; 43(9-10):359-369. PubMed ID: 29206498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adipose-derived mesenchymal stem cell therapy for reverse bleomycin-induced experimental pulmonary fibrosis.
    Zhao X; Wu J; Yuan R; Li Y; Yang Q; Wu B; Zhai X; Wang J; Magalon J; Sabatier F; Daumas A; Zhu WM; Zhu N
    Sci Rep; 2023 Aug; 13(1):13183. PubMed ID: 37580529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of lecithinized superoxide dismutase and/or pirfenidone against bleomycin-induced pulmonary fibrosis.
    Tanaka KI; Azuma A; Miyazaki Y; Sato K; Mizushima T
    Chest; 2012 Oct; 142(4):1011-1019. PubMed ID: 22459774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leech extract alleviates idiopathic pulmonary fibrosis by TGF-β1/Smad3 signaling pathway.
    Zhang Y; Lu YB; Zhu WJ; Gong XX; Qian R; Lu YJ; Li Y; Yao WF; Bao BH; Zhang Y; Zhang L; Cheng FF
    J Ethnopharmacol; 2024 Apr; 324():117737. PubMed ID: 38228229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The antifibrotic effects and mechanisms of microRNA-26a action in idiopathic pulmonary fibrosis.
    Liang H; Xu C; Pan Z; Zhang Y; Xu Z; Chen Y; Li T; Li X; Liu Y; Huangfu L; Lu Y; Zhang Z; Yang B; Gitau S; Lu Y; Shan H; Du Z
    Mol Ther; 2014 Jun; 22(6):1122-1133. PubMed ID: 24594795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroSPECT Imaging-Guided Treatment of Idiopathic Pulmonary Fibrosis in Mice with a Vimentin-Targeting
    Zhang D; Zhuang R; Li J; Lv Y; Yang X; Pan W; Zhang X
    Mol Pharm; 2021 Nov; 18(11):4140-4147. PubMed ID: 34657437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.